본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Development and cross-validation of prediction equations for body composition in adult cancer survivors from the Korean National Health and Nutrition Examination Survey (KNHANES) Choi Jinyoung
(National Hospice Center)

Kim Kyuwoong
(Hospice Care Quality & Education Team)
. Development and cross-validation of prediction equations for body composition in adult cancer survivors from the Korean National Health and Nutrition Examination Survey (KNHANES). PLOS ONE. 2024-10-04; 2024; 19(10:e0309061~. IF 2.9 (2023)
The effect of the expansion of the Personal Assistance Service Program on the uptake of the National Health Screening in people with severe disability
()

Kim Woo Rim
(Hospice Policy & Planning Team)
. The effect of the expansion of the Personal Assistance Service Program on the uptake of the National Health Screening in people with severe disability. JOURNAL OF PUBLIC HEALTH. 2024-10-03; 2024; 46(4):537~543. IF 3.6 (2023)
Cardiovascular Outcomes Associated With Isolated Systolic or Diastolic Hypertension According to the 2017 AHA/ACC Guideline in Adult Cancer Survivors Kim Kyuwoong
(Hospice Care Quality & Education Team)


()
. Cardiovascular Outcomes Associated With Isolated Systolic or Diastolic Hypertension According to the 2017 AHA/ACC Guideline in Adult Cancer Survivors. JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2024-09-30; 2024; 13(19):e036266~. IF 5 (2023)
Survival of lung cancer patients according to screening eligibility using Korean Lung Cancer Registry 2014-2016 Cha Hyo Soung
(Data Planning & Technology Team)

Lee Sang Won
(Data Curation & Construction Team)
. Survival of lung cancer patients according to screening eligibility using Korean Lung Cancer Registry 2014-2016. SCIENTIFIC REPORTS. 2024-09-29; 2024; 14:22585~. IF 3.8 (2023)
Cost-effectiveness of next-generation sequencing for advanced EGFR/ALK-negative non-small cell lung cancer Kang Sokbom
(Division of Clinical Research)


()
. Cost-effectiveness of next-generation sequencing for advanced EGFR/ALK-negative non-small cell lung cancer. LUNG CANCER. 2024-09-28; 2024; 197:107970~. IF 4.5 (2023)
Prevalence Estimation of the PALB2 Germline Variant in East Asians and Koreans through Population Database Analysis Sun-Young Kong
(Targeted Therapy Branch)


()
. Prevalence Estimation of the PALB2 Germline Variant in East Asians and Koreans through Population Database Analysis. CANCERS. 2024-09-28; 2024; 16(19):3318~. IF 4.5 (2023)
Use of Antiperspirant Products and Risk of Breast Cancer: A Meta-Analysis of Case-Control Studies Myung, Seung-Kwon
(Department of Cancer AI and Digital Health)

Thao Thi Kim TRINH
(Department of Cancer Control and Population Health)
. Use of Antiperspirant Products and Risk of Breast Cancer: A Meta-Analysis of Case-Control Studies. CANCER INVESTIGATION. 2024-09-26; 2024; 42(9):782~792. IF 1.8 (2023)
Reply to Letter regarding Cho Yu Ri
(Targeted Therapy Branch)

Cho Yu Ri
(Targeted Therapy Branch)
. Reply to Letter regarding "Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis". CLINICAL AND MOLECULAR HEPATOLOGY. 2024-09-24; 2024; 31(1):e103~e104. IF 14 (2023)
Correspondence to letter to the editor on Cho Yu Ri
(Targeted Therapy Branch)

Cho Yu Ri
(Targeted Therapy Branch)
. Correspondence to letter to the editor on "Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis". CLINICAL AND MOLECULAR HEPATOLOGY. 2024-09-24; 2024; 31:103~104. IF 14 (2023)
SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancer Kim Jung Hyun
(Cancer Metastasis Branch)

Park Seong Sik
(Cancer Metastasis Branch)
. SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancer. BRITISH JOURNAL OF CANCER. 2024-09-23; 2024; 131:1437~1449. IF 6.4 (2023)